Print this page         

What's New at FDA  Members only

What's New at EMA Members only

What’s New at MHLW Members only

April 2013

15 Apr 2013 EC introduces Quality Risk Management into revised Guideline on Good Distribution; ISPE helps Members prepare
11 Apr 2013 Medicines and Healthcare Products Regulatory Agency launches its 2013-2018 corporate plan
10 Apr 2013 US FDA publishes budget request for fiscal year 2014
08 Apr 2013 Japanese MHLW joins Japan’s first Public-Private Partnership to facilitate the R&D of new health technologies for the developing world
08 Apr 2013 China obtains ISO/TC150/SC7 voting rights


March 2013

21 Mar 2013 Chinese SFDA adopts newly revised Good Supply Practice for Pharmaceutical Products
19 Mar 2013 Dutch Medicines Evaluation Board releases public consultation on its Strategic Business Plan for 2014-2018
19 Mar 2013 US FDA names Kathleen Uhl acting director, office of generic drugs
15 Mar 2013 European Medicines Agency and European Commission renew confidentiality arrangement with Canada
15 Mar 2013 European Medicines Agency updates product information template to label medicines subject to additional monitoring and encourage adverse ...
14 Mar 2013 European Union Adopts Good Distribution Practice Guidelines
13 Mar 2013 Working with the US FDA Office of the Ombudsman
13 Mar 2013 European Medicines Agency focuses on new legislation, increased efficiency and transparency in 2013 work programme
12 Mar 2013 British MHRA marks first ever successful prosecution under Good Laboratory Practice Regulations
12 Mar 2013 China Healthcare Outlook: The MOH has Officially Launched the Newly-Edited GMP Standards
11 Mar 2013 British MHRA launches an ‘Innovation Office’ to encourage the development of novel medical products and devices
04 Mar 2013 Canada Publishes Information on Classification of Health Products at the Device-Drug Interface
01 Mar 2013 Tackling medication errors: European Medicines Agency workshop calls for coordinated EU approach


February 2013

28 Feb 2013 Chinese SFDA issues Opinions on Deepening Drug Evaluation and Approval Reform and Further Encouraging Drug Innovation
26 Feb 2013 British MHRA looking to appoint new Chief Executive



  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile



Design Considerations for WFI Distillation Systems Part 4
Thursday, 26 May 2016 13.05

Direct Access to Quality Manufacturing Experts
Wednesday, 25 May 2016 13.05

Broadening Pharmaceutical Training Footprint in Europe
Tuesday, 24 May 2016 19.05